FDA's August 2026 warning letter to Fresenius Kabi's Ogden, Utah plant exposes how sponsor oversight of CMOs fails long ...

A landmark Nature Medicine RCT found AI improved clinician decisions but not patient outcomes, exposing the fatal flaw in how ...

Clinical trial sites should establish data infrastructure before deploying AI tools, according to industry experts and recent ...

Ascendis will present sentinel cohort data from the reACHin Trial of navepegritide infant trial at ESPE 2026, extending the ...

New Nature Neuroscience data shows MCU inhibition blocks drug reward without touching natural reward circuits, a mechanistic ...

Fortrea's $45M acquisition of Worldwide Clinical Trials' early-phase division reshapes Phase I site networks and vendor ...

Myriad bioscaffolds demonstrated a 0.7% deep infection rate in soft tissue reconstruction across 411 patients, significantly ...

Tekton Research sites enrolled 60 participants in Phase 2 obesity trial, tripling their combined enrollment goal and ...

Clover's RSV-hMPV vaccine produced 6-to-9-fold antibody rises in Phase 2, with no immune interference and strong safety.

Rather than stimulating native soluble guanylate cyclase the way sGC stimulators do, mosliciguat directly activates the ...

Canada's drug agency recommends conditional reimbursement for palopegteriparatide in hypoparathyroidism, pending price ...

FDA guidance expands cancer trial eligibility to include patients with ECOG PS 2, reshaping enrollment models and operational ...